These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8026520)

  • 1. Presentation of an exogenous antigen by major histocompatibility complex class I molecules.
    Ulmer JB; Donnelly JJ; Liu MA
    Eur J Immunol; 1994 Jul; 24(7):1590-6. PubMed ID: 8026520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin.
    Donnelly JJ; Ulmer JB; Hawe LA; Friedman A; Shi XP; Leander KR; Shiver JW; Oliff AI; Martinez D; Montgomery D
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3530-4. PubMed ID: 7682709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of ATP-dependent Pseudomonas exotoxin translocation from a late recycling compartment in lymphocyte intoxication procedure.
    Alami M; Taupiac MP; Reggio H; Bienvenüe A; Beaumelle B
    Mol Biol Cell; 1998 Feb; 9(2):387-402. PubMed ID: 9450963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas exotoxin-mediated delivery of exogenous antigens to MHC class I and class II processing pathways.
    Lippolis JD; Denis-Mize KS; Brinckerhoff LH; Slingluff CL; Galloway DR; Engelhard VH
    Cell Immunol; 2000 Aug; 203(2):75-83. PubMed ID: 11006005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.
    Zweerink HJ; Gammon MC; Utz U; Sauma SY; Harrer T; Hawkins JC; Johnson RP; Sirotina A; Hermes JD; Walker BD
    J Immunol; 1993 Mar; 150(5):1763-71. PubMed ID: 7679694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway.
    Noakes KL; Teisserenc HT; Lord JM; Dunbar PR; Cerundolo V; Roberts LM
    FEBS Lett; 1999 Jun; 453(1-2):95-9. PubMed ID: 10403383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo.
    Schutze-Redelmeier MP; Gournier H; Garcia-Pons F; Moussa M; Joliot AH; Volovitch M; Prochiantz A; Lemonnier FA
    J Immunol; 1996 Jul; 157(2):650-5. PubMed ID: 8752913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
    Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
    J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
    Bodmer H; Ogg G; Gotch F; McMichael A
    Nature; 1989 Nov; 342(6248):443-6. PubMed ID: 2479838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous presentation of a nascent antigenic epitope to CD8+ CTL is more efficient than exogenous presentation.
    Hahn YS; Hahn CS; Braciale TJ
    Immunol Cell Biol; 1996 Oct; 74(5):394-400. PubMed ID: 8912001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR
    Science; 1989 Jun; 244(4908):1072-5. PubMed ID: 2471266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway.
    Carbonetti NH; Irish TJ; Chen CH; O'Connell CB; Hadley GA; McNamara U; Tuskan RG; Lewis GK
    Infect Immun; 1999 Feb; 67(2):602-7. PubMed ID: 9916065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity.
    Reiter Y; Di Carlo A; Fugger L; Engberg J; Pastan I
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4631-6. PubMed ID: 9114042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL.
    Hammond SA; Johnson RP; Kalams SA; Walker BD; Takiguchi M; Safrit JT; Koup RA; Siliciano RF
    J Immunol; 1995 Jun; 154(11):6140-56. PubMed ID: 7538543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL.
    Seetharam S; Chaudhary VK; FitzGerald D; Pastan I
    J Biol Chem; 1991 Sep; 266(26):17376-81. PubMed ID: 1910044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells.
    Voeten JT; Rimmelzwaan GF; Nieuwkoop NJ; Fouchier RA; Osterhaus AD
    Clin Exp Immunol; 2001 Sep; 125(3):423-31. PubMed ID: 11531950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier-mediated uptake and presentation of a major histocompatibility complex class I-restricted peptide.
    Brander C; Wyss-Coray T; Mauri D; Bettens F; Pichler WJ
    Eur J Immunol; 1993 Dec; 23(12):3217-23. PubMed ID: 8258336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.